Absence of Relationships between L-Dopa Plasma Levels and Therapeutic Effect in Parkinson’s Disease Treated with L-Dopa
- 1 January 1976
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 14 (3) , 219-228
- https://doi.org/10.1159/000114743
Abstract
The plasma concentration of dopa was studied in 15 parkinsonian patients after a single administration L-dopa to correlate plasma dopa concentration and clinical performance as a result of tests before and after a single dose of dopa. The absolute absence of correlation between dopa levels in plasma and clinical improvement during long-term treatment is confirmed. Clinical responses to the performance tests were not related to the concentration of circulating L-dopa in the plasma. Dopa levels cannot be useful in clinical practice but only for the prevention of high plasma L-dopa concentrations which often cause side-effects.This publication has 2 references indexed in Scilit:
- The fluorometric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole techniqueAnalytical Biochemistry, 1968
- A sensitive method for spectrophotofluorometric assay of catecholaminesInternational Journal of Neuropharmacology, 1964